Treatment for MRSA no longer more costly than for susceptible Staph aureus infections

May 10, 2018, Center for Disease Dynamics, Economics & Policy
Credit: CC0 Public Domain

A new study from the Center for Disease Dynamics, Economics & Policy (CDDEP), with collaborators from Johns Hopkins University and University of Texas Southwestern Medical Center, found that infections caused by one of the most common drug resistant bacteria in the US—methicillin-resistant Staphylococcus aureus, known as MRSA—are no more expensive to treat than MSSA, the methicillin-susceptible version of the same bacteria. These findings, published in the journal Clinical Infectious Diseases, are contrary to earlier studies that have found that MRSA was much more expensive to treat than MSSA.

The researchers used national hospitalization data to analyze the costs of treating diagnosed with S. aureus infections from 2010 through 2014. Costs were assessed in aggregate and by three types: S. aureus blood stream infections, S. aureus pneumonia infections, and other S. aureus infections, primarily skin and . Surprisingly, MSSA infections were found to be costlier than MRSA infections across all infection types. However, after controlling for differences in the patient populations infected with MRSA and MSSA, only skin and soft tissue MSSA infections were estimated to be costlier - while for other infection sites the costs were similar.

"Contrary to historical studies at the hospital-level, which suggested that MRSA infections were significantly more expensive that MSSA infections, nationally we found that MRSA-related hospitalization costs were approximately the same as or less expensive than hospitalizations with MSSA infections," according to the study's lead author Dr. Eili Klein, Research Fellow at CDDEP. However, researchers noted that patients with MRSA infections had a greater likelihood of mortality than patients with MSSA.

One potential reason for the convergence in costs of treating MSSA and MRSA is the emergence and spread of community-associated strains of MRSA. These strains, which are genetically distinct from hospital-associated strains and have different infection patterns and antibiotic susceptibilities, surged in the early 2000s. This may have led physicians to empirically treat all potential S. aureus infections as if they were MRSA, which may have improved outcomes and costs for treating infected MRSA patients while increasing costs for treatment of MSSA patients.

The study was unable to determine if the change was a function of improved diagnostic tests, better empiric prescribing, or changes in hospital infection control. "Changes in the health insurance system may have also affected hospital care and treatment ," continued Dr. Klein. "Further research is needed to better understand the underlying reasons for the change and the implications of this research for the broader crisis of antibiotic resistance."

Explore further: Pediatric musculoskeletal MRSA infections on the rise

Related Stories

Pediatric musculoskeletal MRSA infections on the rise

October 26, 2013
Pediatric musculoskeletal Staphylococcus aureus bacterial infections have been evolving over the past decade, with more children diagnosed with the more virulent, methicillin-resistant Staphylococcus aureus (MRSA) today than ...

Staph sepsis increases mortality in preterm infants

March 12, 2012
(HealthDay) -- Only about 1 percent of very low birth weight (VLBW) infants develop methicillin-resistant Staphylococcus aureus (MRSA) infections, and the morbidity and mortality are similar to that seen in infants with methicillin-susceptible ...

Socio-economic factors affect disease spread

February 12, 2014
Maori and Pacific people are at highest risk of an increasing rate of Staphylococcus aureus disease in New Zealand.

MRSA rates varied dramatically across geographic areas

June 2, 2014
The rates of community-onset methicillin-resistant Staphylococcus aureus (CO-MRSA) varied dramatically among academic medical centers in California, New York, Illinois and North Carolina, suggesting there is not a uniform ...

Relative proportion of MRSA increasing in S. aureus isolates

April 18, 2013
(HealthDay)—The relative proportion of methicillin-resistant Staphylococcus aureus (MRSA) is increasing in S. aureus isolates, and methicillin-sensitive S. aureus (MSSA) is becoming increasingly resistant to antibiotics, ...

Superbug MRSA identified in US wastewater treatment plants

November 5, 2012
A team led by researchers at the University of Maryland School of Public Health has found that the "superbug" methicillin-resistant Staphylococcus aureus (MRSA) is prevalent at several U.S. wastewater treatment plants (WWTPs). ...

Recommended for you

Small-scale poultry farming could mean big problem in developing countries

December 16, 2018
Small-scale farming in developing countries provides those in rural communities with income and access to protein, but it may have a large impact on antibiotic resistance, according to a new University of Michigan study.

RNA processing and antiviral immunity

December 14, 2018
The RIG-I like receptors (RLRs) are intracellular enzyme sentries that detect viral infection and initiate a first line of antiviral defense. The cellular molecules that activate RLRs in vivo are not clear.

Faster test for Ebola shows promising results in field trials

December 13, 2018
A team of researchers with members from the U.S., Senegal and Guinea, in cooperation with Becton, Dickinson and Company (BD), has developed a faster test for the Ebola virus than those currently in use. In their paper published ...

Drug targets for Ebola, Dengue, and Zika viruses found in lab study

December 13, 2018
No drugs are currently available to treat Ebola, Dengue, or Zika viruses, which infect millions of people every year and result in severe illness, birth defects, and even death. New research from the Gladstone Institutes ...

Urbanisation and air travel leading to growing risk of pandemic

December 13, 2018
Increased arrivals by air and urbanisation are the two main factors leading to a growing vulnerability to pandemics in our cities, a University of Sydney research team has found.

Researchers discover new interactions between Ebola virus and human proteins

December 13, 2018
Several new connections have been discovered between the proteins of the Ebola virus and human host cells, a finding that provides insight on ways to prevent the deadly Ebola virus from reproducing and could lead to novel ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.